The firm invests in early and late stage companies that use novel scientific approaches to solve significant unmet needs, and also invests in companies that use science-based innovations to address market needs in life sciences and IT. New Science Ventures' team has expertise in strategy, operations, cost management, and leadership development. Founded in 2004 and based in Greenwich, Connecticut, the firm seeks to invest in various sectors such as pharmaceuticals, biotechnology, healthcare devices, healthcare technology systems, consumer durables, life sciences, health tech, information technology, and digital health in the US and Europe.